Kyrgyzstan IVF Post-Arrival Checklist: Full Process from Registration to Cycle Start

I. First Stop After Arrival: Why Re-testing is Necessary

Last month, I accompanied a couple from Guangzhou to register at a reproductive center in Bishkek. The wife, Sister Li, brought a stack of test reports from China, nearly as thick as a magazine. She thought she could start the cycle directly upon arrival. However, the doctor flipped through the reports, pulled out three, and said, "These three items need to be redone in our lab; the others can be used for now." Sister Li was stunned—her AMH and infectious disease screening were done three months ago.

This situation is very typical. Many patients mistakenly believe that "reports from top-tier hospitals in China are universally accepted." In reality, overseas reproductive centers have strict requirements regarding the validity period, testing methods, and issuing institutions for test results. What tests are needed after arrival depends not on the reports you bring, but on the certification standards of the local lab, your age, medical history, and the treatment plan to be used.

II. Direct Answer: Post-Arrival Test Checklist (Table)

The following are the general testing requirements for first-time patients at mainstream reproductive centers in Bishkek (such as ReproArt, Viva NRC, etc.), divided into mandatory items and optional add-ons.

Key Point: If bringing reports from China, infectious disease screening and semen analysis are the two most likely to require re-testing. This is because different countries have different standards for testing reagents, cut-off values, and institutional qualifications. Labs in Bishkek typically only accept reports from their own or designated partner institutions.

III. Why "Domestic Reports May Not Be Accepted"

It's not that overseas doctors are deliberately difficult. Assisted reproduction is a medical practice highly dependent on laboratory standards. For example, China commonly uses the fourth-generation ELISA for HIV testing, while some centers in Kyrgyzstan use chemiluminescence. The sensitivity of these two methods differs. If a domestic report is used directly and a discrepancy arises due to methodological differences, liability becomes very difficult to assign.

Another reason: the validity of test results is dynamic. Although AMH is relatively stable, thyroid function and infectious disease markers can fluctuate over time. For patients over 38 or with a risk of poor ovarian response, doctors will require shorter re-testing intervals.

IV. Easily Overlooked Details: Documents and Registration Materials

The first thing after arrival is not blood draw, but registration. Reproductive centers in Bishkek require the following original or notarized documents:

• Passports of both spouses (validity must cover the entire treatment cycle; recommended remaining validity > 6 months)
• Marriage certificate (must be translated and notarized; some centers accept Chinese-Russian notarized documents from domestic notary offices)
• Visa (treatment visa or medical visa; tourist visas are usually not accepted for registration)
• All previous test reports (originals + translations; it is recommended to have them stamped by an authorized translation agency in Bishkek in advance)

The most common pitfall is marriage certificate notarization. Some domestic notary offices only provide notarization in Chinese, while Kyrgyzstan requires Russian or English translation. If the language of the notarized document is incorrect upon arrival, you will need to find a translation notary in Bishkek, which takes 2-3 business days.

V. Actual Process: Timeline from Arrival to Cycle Start

Example: A woman with AMH 1.2, age 36, no significant medical history:

• Day 1 (Arrival): Arrive in Bishkek in the afternoon, check into apartment. Contact coordinator in the evening to confirm registration time for the next day.
• Day 2: Arrive at center at 9:00 AM for registration, submit passports and notarized marriage certificate. Female: blood draw (AMH, infectious diseases, thyroid function). Male: semen analysis + infectious disease blood draw. Male takes approx. 1.5 hours, female approx. 2 hours.
• Day 3: Wait for results. Semen analysis results available same day; AMH and infectious diseases take 24 hours. Receive most results in the afternoon; doctor provides preliminary assessment.
• Day 4: If menstrual cycle timing is appropriate, perform transvaginal ultrasound for antral follicle count and blood draw for sex hormone panel (provided it is day 2-3 of menstruation). Doctor formulates ovarian stimulation plan based on all results.
• Day 5-7: If all tests are normal, begin stimulation injections. From arrival to cycle start, the fastest is 5-7 days.

If the menstrual cycle is not aligned, a wait of 10-15 days may be necessary. This is why it is recommended to share the date of your last menstrual period with the coordinator before departure for advance planning.

VI. Interpreting Test Results: What the Doctor is Looking For

Using AMH as an example, Bishkek reproductive doctors interpret values similarly to China, but with slightly different thresholds:

• AMH ≥ 1.2: Indicates normal ovarian response; standard starting dose is appropriate.
• AMH 0.6-1.1: Suggests diminished reserve; doctors tend to use mild stimulation or antagonist protocols and may increase the starting FSH dose.
• AMH < 0.6: Indicates poor ovarian response; doctors will recommend a more comprehensive evaluation, including chromosome and uterine cavity assessment, and will clearly inform you that the expected number of retrieved eggs may be less than 3-4.

FSH > 10 IU/L accompanied by shortened menstrual cycles (<25 days) suggests diminished ovarian reserve. Antral Follicle Count (AFC) with a bilateral total <5 also indicates poor response.

In male semen analysis, Sperm DNA Fragmentation Index (DFI) is a crucial indicator for Bishkek reproductive doctors. If DFI > 30%, even with normal sperm concentration and motility, antioxidant therapy or the use of testicular sperm may be recommended.

VII. Frequently Asked Questions: Arrival Tests

Q: I just had an AMH test in China a month ago. Do I need to repeat it?
A: If the report is from a reputable top-tier hospital and the method is electrochemiluminescence, some centers accept AMH results within 3 months. However, the doctor needs to see comparative data with the local lab during registration. The safest approach is to retest upon arrival, as the AMH test costs only about $80-120, far less than the risk of protocol deviation due to incomparable data.

Q: Is chromosome testing mandatory?
A: Not mandatory, but strongly recommended if you are over 38, have a history of recurrent miscarriage, or previous embryonic chromosomal abnormalities. Karyotype analysis takes 7-10 business days, so it's best to complete it in China before departure or have blood drawn on the first day after arrival to avoid delays.

Q: Does everyone need a hysteroscopy?
A: No. It is only required if there is heterogeneous endometrial echo, previous implantation failure, recurrent uterine fluid, or polyps/adhesions on ultrasound. Hysteroscopy is usually scheduled 3-7 days after menstruation ends, is a day surgery, and you can leave after one hour of observation.

VIII. Practitioner Observations: Testing Focus by Age Group

In my three years in Bishkek, among the patients I've handled, those under 35 generally have the smoothest post-arrival testing. Ovarian reserve is typically normal, and doctors only require the basic four (AMH, sex hormones, antral follicle count, semen analysis) plus infectious disease screening. Assessment can be completed in 2-3 days.

For the 38-42 age group, doctors proactively add chromosome karyotype analysis and thyroid function. The risk of chromosomal aneuploidy begins to rise in this age group, and doctors need to determine before the cycle whether PGT-A is necessary. Additionally, thyroid dysfunction is common in perimenopausal women. If TSH > 4.0 mIU/L, it must be adjusted to below 2.5 with levothyroxine before starting stimulation.

For patients over 42, post-arrival testing is more complex. In addition to the above, doctors may require endometrial microbiome testing (if previous implantation failed) and comprehensive coagulation panel. Endometrial receptivity decreases in older women, and the rate of microbial imbalance increases; early intervention can improve implantation rates.

IX. Handling Special Situations: What if Tests are Abnormal

If post-arrival tests reveal HIV or Hepatitis B positivity, Bishkek reproductive centers will not directly refuse treatment but will initiate standard precaution protocols. HIV-positive patients must first go to a local infectious disease hospital to assess viral load and CD4 count. Once confirmed to be under control, the center can use specialized sperm washing procedures and incubators to prevent cross-contamination. Hepatitis B-positive patients with DNA levels below the detection limit can also proceed with the cycle, but the newborn must receive immunoglobulin and vaccination within 12 hours of birth.

If AMH is below 0.4, the doctor will have a detailed discussion with you, explaining that the expected number of retrieved eggs may be 1-2, and discuss whether to proceed with a natural cycle or mild stimulation protocol. In this case, the testing period may be extended by 1-2 months, as multiple egg retrievals may be needed to accumulate embryos.

X. Risk Reminder: Testing is Not a One-Time Event

Passing the initial round of post-arrival tests does not mean no further tests are needed throughout the cycle. During ovarian stimulation, doctors will monitor estradiol levels and follicle growth every 2-3 days, and may re-check LH and progesterone. If there is a tendency for ovarian hyperstimulation, additional blood counts and liver/kidney function tests may be ordered. Furthermore, semen analysis is re-confirmed on the day of egg retrieval to ensure the final sperm quality meets standards.

Special Reminder: Please scan and back up all original test reports. Reproductive centers in Bishkek usually only retain reports issued by their own lab. If you need them for other medical purposes back in China, be sure to request copies or electronic versions from the lab before leaving the country.